Issue #701
Jan 3, 2020
The Oasis

Newsletter


The newsletter with chart analysis for stocks and stock indexes

Stock Indexes Analysis/Evaluation


New Year, New Administration, New Changes?

DOW Friday closing price - 30606
SPX Friday closing price - 3756
NASDAQ Friday closing price - 12888

Across the board, all indexes closed out the year by making new all-time high weekly closes and on the highs of the week, suggesting the first course of action for the week will be to the upside and above last week's highs (DOW at 30637, SPX at 3760, and NASDAQ at 12973). Nonetheless, on 4 of the last 7 years when that scenario occurred, the indexes began a correction either the first or second week of the New Year and on the other 3 occasions, there was only one time (2017 when Trump took office) where the indexes closed on the highs of the year and followed through to the upside. On the other 2 occasions, the indexes had closed out the year at the bottom of a small or medium sized correction and where the indexes were actually oversold (not overbought as they are now). As such and if recent history (last 7 years) holds true, there is a 75% probability (or higher) that the indexes will begin a correction either starting the first week of the year or by the second at the latest.

One very important thing to watch this week is the runoff elections in Georgia that are occurring on Tuesday January 5th. If the Democrats win both seats, they will have control of the Senate and if that occurs, some type of raising of taxes will likely occur and that would be a negative for the market. Even if only one of the Democrats win, the Republicans will only have a 1 seat advantage in the Senate and 1 seat is not a majority that can be counted on, meaning that the traders will be wary and careful regarding purchasing stocks, especially at these highly overbought conditions. In addition and based on the information above regarding the past 7 year history that suggests that some form of correction is likely to begin within the first 2 weeks of the year, either way the probabilities favor some type of pullback as January 20th approaches with the only question being whether it will be a small pullback/correction or a larger one.

There is no resistance above on the charts where the bears can gather to mount a strong and combined/concerted attack to push the market down so it will all be about the rate of momentum to the upside that will be watched. Evidently, with the closes on the high of the week/month/year and no resistance above, the bulls have open air and if the bulls are a bullish on the 2021 future of the market, they will begin the year with a strong buying spree. If that does not occur by Wednesday (momentum continuing after the runoff election results are out), the selling will likely come in and with absolutely no support levels close by, it could be a deep red week by the end of the week.

The last 7 trading days have all shown higher highs and higher lows, meaning that there is no support (pivotal point) nearby. In fact, you have to go back to Monday 21st (2 weeks ago) to find support. In the DOW it is at 29755, in the SPX, it is at 3636 and in the NASDAQ it is at 12525. Those levels of support are 3% below Friday's closes and if broken, the previous all-time high daily closes would become the immediate target. Those levels are 29551, 3580, and 12056 respectively. Those are the level below that could be reached this week if and when the bulls fail to keep the momentum going to the upside after Tuesday's runoff election.

That is about as much as can be said at this time. Either way, the probabilities do favor the bears this week.


GOLD generated a new 2-month high weekly close and closed on the high of the week, suggesting further upside above last week's high at $1904 will be seen this week. There is some intraweek resistance at $1912 (minor) and then nothing until $1939 (minor to perhaps decent). On a daily closing basis, there is minor resistance at $1920 and then a bit stronger at $1928. Short term pivotal daily close support is found at $1890 ($1877 on an intraweek basis) that should not be broken if Gold is to resume its previous uptrend. Pivotal intraweek support is found at $1820 and pivotal resistance is found at $1966 that if broken, would confirm the correction is totally over and strongly suggest the uptrend has restarted and the all-time high at $2089 will be tested and likely broken. Probabilities favor the bulls.

OIL generated an uneventful week, having closed $.30 cents above the previous week's close but still below the recent 10-month high weekly close at 49.10. Nonetheless, oil closed in the upper half of the week's trading range, suggesting further upside above last week's high at 48.97 will be seen this week. The chart is not yet fulfilled to the upside given that the objective of reaching the 49.71-50.13 level on a weekly closing basis, is still viable. If that level is not reached, it would suggest the bears still have a measure of control and that the support between 45.50 and 46.00 would likely not hold up. If the upside objective is reached, that lower support level is likely to hold up on any correction seen at the beginning of the year. Probabilities favor the bulls this week.


Stock Analysis/Evaluation
CHART Outlooks

The New Year is upon us and a new administration will take over in 2 weeks. New administrations do generate changes and often in the way traders trade the market. Trump brought a bullish scenario to the market. Biden not so much, but how much less is yet to be seen. The normal trading seen in the market history has been one of peaks and valleys that was not the prevailing scenario under Trump. I do believe though, that it will be the scenario under Biden, meaning a bit more dependence on charts than has been seen the past 4 year.

As far as mentions for this week, 2 of the 3 mentions given the past two weeks are still viable and likely to reach the desired entry points this week. I am also including one new mention on an existing held stock, either to add positions or start a new one.

MRNA Friday Closing Price - 104.47

MRNA appreciated over 600% in price between May and December based on the anticipation of a Covid-19 vaccine being produced before the end of the year. That anticipation turned to fact a few weeks ago but it has become the classic case of "buy the anticipation and sell the fact" adage as the stock has dropped 43% in value over the past 4 weeks.

Though the drop seen in MRNA strongly suggests that the 178.50 high seen on December 1st is now a valid top that requires new positive fundamentals to be broken, the stock is still showing a lot of profit potential for this year with the vaccine that is now being distributed. This move down is likely to be an attempt to discover the minimum true value price of the stock and build a support base from which traders can buy with confidence. Such a level is likely to be the previous all-time high made in July of last year at 94.85. Then again, with the positives economics of the vaccine already proven, it is possible that buying interest will begin to appear before that previous high is neared, meaning that a drop down to that specific level might not occur.

The $100 level is a psychological support area that is likely to be reached but not necessarily broken, at least not below the $97 level, suggesting that purchases of some shares could begin with a drop below 100.00 and a full complement of shares-to-be-bought completed either on a drop down to 94.85 or when a support level has been built and buying has begun to be seen.

MRNA did close near the low of the week and further downside below last week's low at 102.66 is expected to be seen. With the stock showing a minimum $20 trading range the past 6 weeks, the probabilities of a drop down to $100, or even down to 94.85 is a high probability for this week, especially considering that 118.94 is now a short term pivotal resistance. Simply stated, the probabilities are high this week that the stock will drop down to the desired entry point of the trade.

To the downside and on an intraweek basis, MRNA chart is showing pivotal support at 88.61 that if broken, would suggest there are some fundamental problems with the company, which at this time are not publicly evident and therefore the support not likely to be broken. This means that a stop loss at 88.51 is a dependable stop loss to be used on a purchase. With this big drop, it is now strongly likely that a top to the upside at 178.50 is set for some time. Nonetheless, a rally back up to test the highs is likely to occur, suggesting that for the next 6 months the stock will be a trading stock rather than an investing stock. To the upside, there are only 2 minor-and-not-likely-to-stop-a-rally resistance levels above before any real resistance is found. There is resistance at 118.94 and then nothing until 147.26. The strong and indicative resistance is found at 163.75 that could be neared but not likely broken, meaning the stock is likely to trade between $100 and $160 for the next 4-6 months. All of these resistance levels are on the daily chart and not the weekly chart, meaning that on any indication that this correction is over, the buying interest is likely to be strong and immediate until the important resistance level is reached.

Purchases of MRNA below 100.00 and using a stop loss at 88.51 and having a $160 objective will offer a 5-1 risk/reward ratio.

My rating on the trade is a 4.25 (on a scale of 1-5 with 5 being the highest).

PFE Friday Closing Price - 36.81

PFE is another company, like MRNA, that has developed a vaccine for the virus but that has also suffered from the "buy the anticipation and sell the fact" adage, given that the stock has dropped 15.8% after the vaccine was approved by the FDA and has begun to be distributed. Nonetheless, PFE is a much more established company that produces many other medical products and therefore the chart action is more predictable, the support stronger, and the price action less, meaning less potential profit but less risk and less volatility. In simple words, a safer stock to trade.

One strong additional reason to choose PFE over MRNA (if you don't want to trade both) is that the stock made a new all-time high 2-years ago and before the pandemic, meaning that the bulls have a clear upside objective to shoot for (and break), whereas MRNA does not. Simply stated, there is a clear path for the traders to trade technically whereas not in the other stock and which offers additional profit potential.

PFE generated another red close week (3rd in a row) and closed in the lower half of the week's trading range, suggesting further downside below last week's low at 36.29 will be seen this week. Nonetheless, the stock did get into the desired entry point area this past week, having closed the gap down at 36.56 that was a magnet to the downside and could have been bought. This did happen at the end of the week and given that the stock was likely to close in the lower half and there is "some" additional room to the downside without the chart changing outlook, I decided to wait for this week to purchase. I will likely be purchasing the stock this week.

PFE does have one additional potential downside objective, being the 200-week MA, currently at 35.81, and it is even possible/probable that the 200-day MA, currently at 38.84, might be reached intraweek as well. One additional MA line that has been relatively dependable is the 100-week MA, currently at 36.25, meaning that there is a lot of support between 34.84 and 36.25 that the chart traders will use to enter a buy trade on the stock.

To the upside and on a weekly closing basis, PFE shows resistance at 36.98, at 38.40 and pivotal at 41.12. On an intraweek basis, those resistance levels are at 37.40, at 38.84 and at 43.02 respectively.

The benefits in 2021 of the vaccine the company has developed are likely to keep the stock in an uptrend or at least with a positive bias, meaning that a break of the 200-week MA at 35.81 is not likely to happen. With the stock having gotten down to 36.29 this past week and within $.38 cents of that support, buying interest will begin to appear this week.

PFE being an established company that depends on many other things not related to the Covid-19 vaccine, has potential to reach (and possibly break) the all-time high 44.05 made 2 years ago in December 2018. Nonetheless, even if only the vaccine benefits are in play, a retest of the recent high at 43.05 is likely to occur, meaning that at the very minimum, a rally back up to the 41.00 level is likely to be seen.

The stop loss on the trade will be at 34.65 and with an entry point around 36.00 and a minimum objective of $41, it means the risk is only $1.35 per share with a minimum profit potential of $5 per share, which is a 3.7-1 risk/reward factor. Purchasing PFE over MRNA offers more security but less profit potential and certainly less volatility.

My rating on the trade is 4.25 (on a scale of 1-5 with 5 being the highest).

In addition:

CRON Friday Closing Price - 6.94

Purchases of CRON below 6.90 and using a stop loss at 6.52 and having a minimum objective of 8.13 will offer a 3.2 risk/reward ratio. For more details, see the Held Stocks Update Section below.

My rating on the trade is a 3.75 (on a scale of 1-5 with 5 being the highest).

Updates
Monthly & Yearly Portfolio Results
Closed Trades, Open Positions and Stop Loss Changes

Status of account for 2007: Profit of $9,758 per 100 shares after losses and commissions were subtracted.
Status of account for 2008: Profit of $14,704 per 100 shares after losses and commissions were subtracted.
Status of account for 2009: Profit of $7,523 per 100 shares after losses and commissions were subtracted.
Status of account for 2010: Profit of $24,045 per 100 shares after losses and commissions were subtracted.
Status of account for 2011: Profit of $3,616 per 100 shares after losses and commissions were subtracted.
Status of account for 2012: Profit of $3,399 per 100 shares after losses and commissions were subtracted.
Status of account for 2013: Profit of $15,886 per 100 shares after losses and commissions were subtracted.
Status of account for 2014: Profit of $21,221 per 100 shares after losses and commissions were subtracted.
Status of account for 2015: Profit of $19,190 per 100 shares after losses and commissions were subtracted.
Status of account for 2016: Loss of $15,134 per 100 shares after losses and commissions were subtracted.
Status of account for 2017: Loss of $9,666 per 100 shares after losses and commissions were subtracted.
Status of account for 2018: Profit of $1,637 per 100 shares after losses and commissions were subtracted
Status of account for 2019: Profit of $13,051per 100 shares after losses and commissions were subtracted

Status of account for 2020, as of 12/1

Loss of $28910 using 100 shares per mention (after commissions & losses)

Closed out profitable trades for December per 100 shares per mention (after commission)

QQQ (short) $204 (2 day trades)
CAT (short) $337 (1 day trade)
W (long) $5264 (3 day trades)
MRNA (short) $694 (1 day trade)
MRNA (long) $ 1005

Closed positions with increase in equity above last months close minus commissions.

MRNA (long) $2472
RIO (long) $1826

Total Profit for December, per 100 shares and after commissions $11,802

Closed out losing trades for December per 100 shares of each mention (including commission)

CAT (short) $82 (1 day trade)
FNV (short) $108 (1 day trade)
MRNA (long) $103 (1 day trade)
MRNA (long) $187
CRON (long) $48

Closed positions with decrease in equity below last months close plus commissions.

NONE

Total Loss for December, per 100 shares, including commissions $528

Open positions in profit per 100 shares per mention as of 12/31

NONE

Open positions with increase in equity above last months close.

W (short) $5710
AU (long) $570
ENG (long) $672
NEM (long) $535
CNX (long) $278 <

Total $7,765

Open positions in loss per 100 shares per mention as of 12/31

NONE

Open positions with decrease in equity below last months close.

CRON (long) $764
QQQ (short) $2824
CAT (short) $2529
AXP (short) $696

Total $6813

Status of trades for month of December per 100 shares on each mention after losses and commission subtracted.

Profit of $12,226

Status of account/portfolio for 2020, as of 12/31

Loss of $16,684

per 100 shares. Ending Results for 2020

Yearly totals:

Total amount of trades for the year = 189
Total amount of different stocks traded = 33
Total amount of profitable trades = 106
Total amount of losing trades = 83
Total amount of trades from last year still open = 8
Total amount of trades from previous years still open - 7
Total amount of months showing profit = 5
Total amount of months showing loss = 7
Percentage of trades/mentions profitable = 56%
Total trades on the long side = 30
Total trades on the short side - 159
Total closed profit for the year $87,797
Total closed losses for the year $38,753
Total positions still open in profit $1293
Total positions still open in loss $60,178
Total Commissions paid $6843
Total profit/losss for year per 100 shares after commissions profit/losses substacted
Loss of $16,684



Updates on Held Stocks

AU generated a negative reversal week, having gone above the previous week's high but then going below the previous week's low and closing red and near the low of the week, suggesting further downside below last week's low at 22.31 will be seen this week. This was a surprising event given that Gold made additional strides to the upside but those strides were not seen in the stock even though there was no negative fundamental news reported. Then again, that was the same story seen in other gold stocks, suggesting it might have something to do with end of the year profit taking or end of the year closure of positions. On a weekly closing basis, the stock did generate a technical failure signal against the failure signal given 2 weeks ago against the bears when the stock closed above 22.75. Then again, the close at 22.62 was not sufficiently lower than 22.75 to make it a clear signal, meaning that the close next Friday is short-term pivotal. On an intraweek basis, the action did not clear up anything as no support levels of consequence were broken, suggesting the action last week was an end-of-the-year aberration. By the same token and with the New Year starting, the action this coming week is likely to be indicative and based on Gold, it should benefit the bulls. The two levels to watch this week based on daily closes are 22.53 and 23.57. Whichever one is broken, will give that side a clear edge. Probabilities favor the bulls.

AXP generated a green weekly close that makes the previous week's close at 117.35 (113.72 on an intraweek basis) into a pivotal support level that if broken will give the bears back their edge and possibly a measure of control. On a daily closing basis, the 113.67 level is just as important. On an intraweek basis, there is some resistance at 122.43 that could be short-term pivotal. With the new administration taking over in 2+ weeks and the 7-year history of the indexes and the New Year action (mentioned above), the probabilities slightly favor the bears. Nonetheless, the stock is still in an uptrend and the burden of proof is on the shoulders of the bears.

BTZI bulls were unable to generate any follow through to the upside after last week's positive action and close near the high of the week and therefore a red close was generated on Friday and at a weekly close support level at .0395 (closed at .0394 on Friday). The stock has now traded in a .02 trading range (between .035 and .055) for the past 52 trading days and a break above either of those levels is likely to bring about further movement in that direction. The stock closed near the low of the week, suggesting further downside below last week's low at .037 will be seen at the beginning of the week, meaning that the bears will have to deal with the pressure first. By the same token, the Biden administration takes over in 18 days and that is supposed to be a fundamental positive to the Cannabis industry and as such, the probabilities have to favor the bulls this week and holding up support.

CAT generated a positive reversal week, having made a new 4-week low and then closing above the previous week's high and only $.19 cents below the all-time high weekly close at 182.21. The stock closed on the high of the week, suggesting further upside above last week's high at 182.23 will be seen this week. The positive reversal, the close near the all-time high weekly close, and the close on the high of the week strongly suggest that the bulls remain in full control and that further gains are to come. By the same token an on an intraweek basis, the bulls still have 2 obstacles to overcome at the most recent high at 183.33 and at the all-time high at 183.81 and given that New Year's history during the past 7 years suggests that a correction will begin the first or second week of the year, does detract from the strength being seen in this stock at this time. Evidently a move below last week's low at 175.11 would be an indicative negative but also a daily close below 176.58 do the same given that a double low close at that level would be broken. As such, 175.11 and 183.81 are the levels to watch this week. Whichever one is broken, would give a decided edge to bulls or bears. Probabilities slightly favor the bulls.

CNX generated a wild week, starting with the $1.26 trading range seen, the gap created on Monday between 11.45 and 11.27, the break of support on the daily chart at 10.55, the positive retest of the intraweek support at 10.00, the successful retest of the 200-day MA, currently at 9.92, and then finishing in the upper half of the week's trading range, suggesting a higher probability of going above last week's high at 11.27 than below last week's low at 10.01. None of this was surprising though, given the pivotal nature of the recent highs that are not yet ready to be broken and the recent volatility that has increased due to the interest in trading the stock. What now? Is the question. The stock has now traded for 37 weeks in testing and trying to break the 200-week MA, which is currently at 11.50. For the past 25 weeks (last 6 months), all dips have been bought and a support base of "consequence" has now been built. In addition, the action seen at the end of last week continues to show buying interest on dips. Metals and ore have been making strides and the dollar continues to weaken and there are no signs that will change with the new administration, meaning that the probabilities favor the bulls and a breakout above the MA line within the next few weeks (if not sooner). For this week though, the gap at 11.45 is likely to be closed but a breakout is not likely to occur, meaning that for the next 1-3 weeks the stock is likely to trade within the 10.00 to 11.70 level but with higher lows and lower highs, which do favor the bulls overall. Probabilities favor the bulls this week.

CRON continued to show weakness, having generated another red weekly close (the 4th in a row) and closing on the low of the week, suggesting further downside below last week's low at 6.90 will be seen this week. Nonetheless, the stock is now reaching an area between 6.52 and 6.63 that is short term pivotal but could also be decisive for the midterm. That area represents a gap that was created on November 6th and that caused the stock to rally up to 9.15 level and that brought about the break of 2 decent intraweek resistance areas at 8.13 and at 9.00 and the break of the previous downtrend when a weekly close above 6.75 was generated. This all means that the gap should "not" be closed and the stock not generate a weekly close below 6.75. With the stock likely to go below 6.90 this week, new purchases (or addition to presently held positions) should be strongly considered using a 6.52 stop loss. The Biden administration should be positive to the Cannabis industry and positive to the stock, meaning that fundamentally the stock should be moving higher and that thought is now put to the test on the charts this week by holding on to the support found here. Interesting to note that if the support here holds (likely), there is no established resistance above until the 8.13 level, meaning that a rally back up to that level could be seen in as little as 2 weeks. Probablities favor the bulls.

ENG had another strong bullish week, having confirmed the break of the 4-year weekly closing high at 2.88 seen last week with a close at 2.95 and this Friday with a close at 3.20. The stock closed in the upper half of the week's trading range, suggesting further upside above last week's high at 3.56 will be seen this week. On a weekly closing basis, there is no resistance above until the 2014 high at 3.84 is reached. Above that, there is weekly close resistance at 5.25 and at 6.19. The probabilities favor the stock rallying up to the $5 level which is where game changing resistance is found. So far, this rally has been more about short-covering from an 11-year downtrend than about anything else. On a daily closing basis, support is now found at 2.86, which should not be broken if the stock is to continue higher (likely). Evidently this week, the objective will be to generate a close above the 3.84 level as well as going above the high seen 6 weeks ago at 4.32. Probabilities strongly favor the bulls.

FCEL generated an inside week but a red weekly close and in the lower half of the week's trading range, suggesting further downside below last week's low at 10.30 will be seen this week. A retest of the breakout above 200-week MA, currently at 9.67, is the objective. Nonetheless and on a daily closing basis, support is found at 10.20 that should hold up if the stock is to go higher as the chart suggests. Daily close resistance is found at 13.42. Probabilities favor the bears this week but overall, the chart favors the bulls for further upside rally up to the $20 level.

NEM bulls failed to make a statement, having generated a red weekly close in spite of Gold closing higher. The 60.47/60.50 level has been short-term pivotal for the past few weeks and on Friday the stock closed at 59.89 and near the low of the week, suggesting further downside below last week's low at 59.42 will be seen. This was not a negative statement but one that suggests the stock is not yet ready to go higher. There is intraweek support at 59.28 and then at 58.29, one of which is likely to be seen this week with the former being probable and the latter unlikely. By the same token, neither level of support is pivotal. Last week's high at 61.64 is pivotal as a break and close above that level would mean the 200-day MA, currently at 60.25, would be broken to the upside again. The truly pivotal area of resistance above is at 62.29. A break of that level would give control back to the bulls. Probabilities slightly favor the bulls though some weakness could be seen at the beginning of the week.

QQQ once again made a new all-time intraweek and weekly closing high and closed on the high of the week, suggesting further upside above last week's high at 314.69 will be seen this week. There is no resistance above so unless the New Year's history outlined above of corrections starting the first or second week of the New Year comes true, the bulls will remain in full control. There is no support below until the low seen on Monday 14 days ago at 303.60 is reached, meaning there are no pivotal levels close by that would work as triggers for selling. As such, a pause in upside momentum is the only signal that needs to be paid attention to. Probabilities favor the bulls.

SRUTF generated almost the identical kind of action as seen the previous week, having generated a low of .034 (vs the previous week at .0329) and the high at .041 (vs the previous week at .0399). The close was green but only by .009 (.0379 vs the previous week at .0370). By the same token, this is basically the same area seen for 9 weeks in a row, meaning another uneventful week. The last 8 weeks, the low weekly close has been .036 and the high weekly close has been .0423, meaning there seems to be no interest at this time from neither the bulls nor the bears. There is intraweek support at .03 and pivotal at .025 and resistance is found at .049, at .0659 and long term pivotal at .080. For the past 33 weeks, with the exception of 2 weeks, the stock has been mainly stagnant in price.

W made a new 23-week weekly closing low and closed on the low of the week, suggesting further downside below last week's low at 224.03 will be seen this week. The 23-week intraweek low is at 221.09 and that is the target support that the bears will be looking to break this week. On an intraweek basis, below 221.09 there is no support until 205.80 and that support is considered minor. Using the daily closing chart, the 200-day MA is currently at 221.54, meaning that there will be a battle between the bulls and the bears at the 221.00 level. A close below the line will generate new selling, especially if confirmed. If that occurs, the likely downside target will become the previous all-time weekly closing high at 169.89. It must also be mentioned that there is a channel built using all the intraweek highs seen since August and the low seen the last week in August that gives the $175-$180 as the objective to be reached on a channel basis. It is evident that the 221.00 level on a daily closing basis is the key this week. The 200-day MA is always an important and indicative line that the bears need to break in order to generate any further downside. The probabilities do not favor the line breaking (on a daily closing basis) unless the uptrend is basically over. A correction in the indexes might help decide that question.


1) ENG - Averaged long at 1.616 (6 mentions). No stop loss at present. Stock closed on Friday at 2.91.

2) BTZI - Averaged long at .215 (2 mentions). No stop loss at present. Stock closed on Friday at .0475.

3) CRON - Averaged long at 10.4275 (4 mentions). No stop loss at present. Stock closed on Friday at 7.48.

4) SRUTF - Purchased at .36. No stop loss at moment. Stock closed on Friday at .037.

5) W - Averaged short at 86.61 (2 mentions). No stop loss at present. Stock closed on Friday at 252.82.

6) CAT - Averaged short at 109.616 (3 mentions). No stop loss at present. Stock closed on Friday at 179.56.

7) QQQ - Averaged short at 192.995 (2 mentions). No stop loss at present. Stock closed on Friday at 309.56.

8) AXP - Averged short at 93.953 (3 mentions). No stop loss at present. Stock closed on Friday at 117.35.

9) AU - Averaged long at 26.106 (6 mentions). No stop loss at present. Stock closed on Friday at 22.85.

10) NEM - Averaged long at 60.742 (5 mentions). No stop loss at present. Stock closed on Friday at 60.48.

11) CNX - Averaged long at 9.10 (2 mentions). No stop loss at present. Stock closed on Friday at 11.48.

12) CRON - Purchased at 7.86. Liquidated at 7.52. Loss on trade of $34 per 100 shares minus commissions.

13) QQQ - Shorted for a day trade at 310.60. Covered shorts at 309.15. Profit on the trade of $145 per 100 shares minus commissions.

14) MRNA - Purchased at 125.27. Liquidated at 124.36. Loss on the trade of $89 per 100 shares plus commissions.


Join The Oasis and receive chart information about stocks you personally follow as well as ideas about other stocks with powerful chart patterns.

Previous Newsletters

View Aug 02, 2020 Newsletter

View Aug 09, 2020 Newsletter

View Aug 16, 2020 Newsletter

View Aug 23, 2020 Newsletter

View Aug 31, 2020 Newsletter

View Sep 06, 2020 Newsletter

View Sep 13, 2020 Newsletter

View Sep 20, 2020 Newsletter

View Sep 27, 2020 Newsletter

View Oct 04, 2020 Newsletter

View Oct 11, 2020 Newsletter

View Oct 18, 2020 Newsletter

View Nov 01, 2020 Newsletter

View Nov 08, 2020 Newsletter

View Nov 15, 2020 Newsletter

View Nov 22, 2020 Newsletter

View Nov 29, 2020 Newsletter

View Dec 06, 2020 Newsletter

View Dec 13, 2020 Newsletter

View Dec 20, 2020 Newsletter

Encyclopedia of Chart Patterns.
A must have for chart aficionados!


Disclaimer

The opinions and commentaries by Mr. De Vito are not a recommendation to buy or sell, but rather a charting guideline, based on his own knowledge and experience, regarding the stocks he is following or that are brought to him by others. Mr. De Vito does not presently offer a track record of his trading experiences. No inference of success and/or failure should be assumed. The information enclosed above, regarding his background, length of trading, and experience, is correct but is not meant to suggest, state, or infer any future success in trading, based on his opinions.

The information herewith included should only be used by investors who are aware of the risk inherent in securities trading. Mr. De Vito accepts no liability whatsoever for any loss arising from any use of the information and/or comments he supplies.




The Oasis is owned by
Oasis Resolutions Inc.